IP Library Granted Patent US 7,709,658
Granted Patent B2
US 7,709,658 · App. 11/988,849 · Granted May 4, 2010

Process for synthesizing a substituted pyrazole

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,709,658
App. No.
11/988,849
Granted
May 4, 2010
Kind
B2
Abstract

The present invention relates to substituted pyrazoles, compositions containing such compounds and methods of treatment. The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.

Claims (17)

1. A process for the synthesis of a compound of formula I:

comprising reacting a compound of formula III:

in the presence of 1,1′-carbonyldiimidazole with an ester of beta-alanine or a salt thereof or solvate thereof to produce an ester of formula II:

wherein R 1 represents an ester forming group, and hydrolyzing the ester of formula II with a base to provide a compound of formula I.

2. A process for the synthesis of a compound of formula II:

wherein R 1 represents an ester forming group, comprising reacting a compound of formula G:

and a compound of formula D:

to produce a compound of formula II.

3. A process for the synthesis of a compound of formula I:

comprising:

(a) reacting compounds of formulas E and F:

in the presence of potassium t-butoxide to produce a compound of formula G:

(b) reacting the compound of formula G with a compound of formula D:

wherein R 1 represents an ester forming group, to produce a compound of formula II:

(c) hydrolyzing the compound of formula II with a base to produce a compound of formula III:

(d) reacting the compound of formula III with a beta alanine ester or a salt or solvate thereof to produce a beta alanyl ester of the compound of formula III, and

(e) hydrolyzing the beta alanyl ester of the compound of formula III to produce a compound of formula I.

Assignments (5)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023906/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2008
From: TAN, LUSHI; HARTNER, FREERICK W.; YOSHIKAWA, NAOKI; LI, WENJIE; MCWILLAMS, JAMES CHRISTOPHER
To: MERCK & CO., INC
Reel/Frame 021203/0061 →